logo

For the Inventor, By the Inventor

Paris, France

Da Volterra


USPTO Granted Patents = 11

% Expired Patents = 54.5


Trademarks = 4

Forward Citations = 35

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Jean De Gunzburg (6 out of 6 patents)

silverMedal Antoine Andremont (5 out of 6 patents)

bronzeMedal Elias Fattal (4 out of 10 patents)

4.  Jean-Denis Docquier (3 out of 3 patents)

5.  Francois Lescure (3 out of 3 patents)

6.  Sandrine Bourgeois (2 out of 3 patents)

7.  Patrick Couvreur (2 out of 25 patents)

8.  Nicolas Tsapis (2 out of 7 patents)

9.  Helene-Celine Huguet (2 out of 2 patents)

10.  Helene Huguet (1 out of 2 patents)

11.  Hélène-Céline Huguet (0 patent)

12.  François Lescure (0 patent)

13.  Tsapis Nicolas (0 patent)

14.  Hélène Huguet (0 patent)

15.  Fattal Elias (0 patent)


11 patents:

1. 11365403 - Beta-lactamase variants (2022-06-21),
2. 11202761 - Formulations for oral delivery of adsorbents in the gut (2021-12-21),
3. 10988749 - Beta-lactamase variants (2021-04-27),
4. 10982205 - Beta-lactamase variants (2021-04-20),
5. 10052288 - Formulations for oral delivery of adsorbents in the gut (2018-08-21),
6. 9968562 - Formulations for oral delivery of adsorbents in the gut (2018-05-15),
7. 8388984 - Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules (2013-03-05),
8. 8273376 - Colonic delivery of metallo-dependent enzymes (2012-09-25),
9. 8106000 - Colonic delivery of adsorbents (2012-01-31),
10. 7833765 - Galenic formulation for colon-targeted delivery of active ingredients (2010-11-16),
11. 7485294 - Galenic pectinate formulation for colon-targeted delivery of antibiotic-inactivating enzymes and method of use thereof (2009-02-03),
Company Overview
Da Volterra is a biopharmaceutical company based in Paris, France, specializing in the development of innovative therapies to combat antibiotic resistance. The organization focuses on creating novel solutions that address the challenges posed by bacterial infections, particularly those associated with antibiotic overuse. With a strong emphasis on research and development, Da Volterra aims to enhance patient outcomes through its cutting-edge technologies and therapeutic approaches, contributing to the global fight against antimicrobial resistance.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

11 Patents

#346 in Paris

#1,583 in France

#51,714 in the World

Paris, FR
Paris, France

Da Volterra

Forward Citations = 35

10 inventors:

goldMedal Jean De Gunzburg (6 out of 6 patents)

silverMedal Antoine Andremont (5 out of 6 patents)

bronzeMedal Elias Fattal (4 out of 10 patents)

4.  Jean-Denis Docquier (3 out of 3 patents)

5.  Francois Lescure (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Da Volterra. Retrieved from https://idiyas.com/company/da-volterra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…